Stay updated with breaking news from Alimera Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
StockNews.com assumed coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research note released on Sunday. The firm issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ ALIM opened at $3.90 on Friday. The business has a fifty day moving average price of $3.56 and […]
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report published on Sunday morning. The brokerage issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ:ALIM opened at $4.08 on Friday. Alimera Sciences has a 52 week low of $1.30 and a 52 week […]
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a report published on Saturday. The firm issued a hold rating on the biopharmaceutical company’s stock. Alimera Sciences Price Performance Shares of NASDAQ:ALIM opened at $3.81 on Friday. The company’s fifty day moving average price is $3.44 and its 200 day moving […]
Analysts’ new coverage for Saturday, December 23rd: StockNews.com began coverage on shares of Aeglea BioTherapeutics (NASDAQ:AGLE). StockNews.com issued a sell rating on the stock. StockNews.com initiated coverage on shares of Ashford (NYSEAMERICAN:AINC). They issued a buy rating on the stock. StockNews.com began coverage on shares of Alimera Sciences (NASDAQ:ALIM). StockNews.com issued a hold rating on […]
StockNews.com started coverage on shares of Alimera Sciences (NASDAQ:ALIM – Free Report) in a research report report published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Separately, HC Wainwright reissued a buy rating and set a $5.00 price objective on shares of Alimera Sciences in a report on Monday, […]